Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial (ATEGE-LIVER)

This study has been terminated.

(Experimental arm (induction + low dose tacrolimus) not effective.)

Sponsor:

Collaborators:

Fresenius AG

Astellas Pharma Inc

Information provided by:

Hospital Clinic of Barcelona

ClinicalTrials.gov Identifier:

NCT00436722

First received: February 16, 2007

Last updated: May 19, 2009

Last verified: May 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)

No publications provided by Hospital Clinic of Barcelona

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Benítez CE, Puig-Pey I, López M, Martínez-Llordella M, Lozano JJ, Bohne F, Londoño MC, García-Valdecasas JC, Bruguera M, Navasa M, Rimola A, Sánchez-Fueyo A. ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. Am J Transplant. 2010 Oct;10(10):2296-304.

To Top